Use of GnRH [gonadotropin-releasing hormone] antagonist (Cetrotide) [cetrorelix] protocol, instead of agonist, to prepare recipients for embryo transfer

Trial Profile

Use of GnRH [gonadotropin-releasing hormone] antagonist (Cetrotide) [cetrorelix] protocol, instead of agonist, to prepare recipients for embryo transfer

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Oct 2010

At a glance

  • Drugs Cetrorelix; Leuprorelin
  • Indications Infertility
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 25 May 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
    • 08 Nov 2008 Interim results were reported at the 64th Annual Meeting of the American Society for Reproductive Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top